Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Original Research
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,797 | Dovepress* | 4,300+ | 148 | 4,448 | |
| PubMed Central* | 497 | 209 | 706 | ||
| Totals | 4,797 | 357 | 5,154 | ||
| *Since 1 October 2022 | |||||
View citations on PubMed Central and Google Scholar